NCT04968392View on ClinicalTrials.gov

Single-shot Adductor Canal Block With Levobupivacaine and Dexmedetomidine in Total Knee Arthroplasty

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

February 1, 2020

Study Completion Date

May 1, 2020

Conditions
Adductor Canal BlockLevobupivacaineDexmedetomidine
Interventions
DRUG

Dexmedetomidine Hydrochloride

20 mL of 0.25% levobupivacaine plus 0.5 µg/kg dexmedetomidine

DRUG

Levobupivacaine

20 mL of 0.25% levobupivacaine plus 1 mL normal saline

Trial Locations (1)

Unknown

Assiut governorate, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04968392 - Single-shot Adductor Canal Block With Levobupivacaine and Dexmedetomidine in Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter